Stephens Consulting, LLC
- SEC CIK
- 0001961632
- Latest filing
- Jan 13, 2026
RVNC holding history
Revance Therapeutics, Inc. in every 13F filed by Stephens Consulting, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVNC overviewAll 13F holders of RVNCFull Q4 2025 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −500−100.0% | Sold out | Holders |
| Q3 2023 | 500 | $5.74K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 500 | $12.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 500 | $16.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 500 | $9.23K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 500 | $13.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 500 | $6.91K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 500 | $9.75K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 500 | $8.16K | <0.1% | – | No prior filing | Holders |